Cargando…
Booster Effect of a Third mRNA-Based COVID-19 Vaccine Dose in Patients with Myeloid Malignancies
| Autores principales: | , , , , , , , , , , , , |
|---|---|
| Formato: | Online Artículo Texto |
| Lenguaje: | English |
| Publicado: |
The American Society of Hematology. Published by Elsevier Inc.
2022
|
| Materias: | |
| Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9671511/ http://dx.doi.org/10.1182/blood-2022-159849 |
| _version_ | 1784832568866111488 |
|---|---|
| author | Mori, Akio Onozawa, Masahiro Kobayashi, Mirei Tsukamoto, Shihori Senjo, Hajime Ishio, Takashi Yokoyama, Emi Izumiyama, Koh Saito, Makoto Muraki, Haruna Morioka, Masanobu Teshima, Takanori Kondo, Takeshi |
| author_facet | Mori, Akio Onozawa, Masahiro Kobayashi, Mirei Tsukamoto, Shihori Senjo, Hajime Ishio, Takashi Yokoyama, Emi Izumiyama, Koh Saito, Makoto Muraki, Haruna Morioka, Masanobu Teshima, Takanori Kondo, Takeshi |
| author_sort | Mori, Akio |
| collection | PubMed |
| description | |
| format | Online Article Text |
| id | pubmed-9671511 |
| institution | National Center for Biotechnology Information |
| language | English |
| publishDate | 2022 |
| publisher | The American Society of Hematology. Published by Elsevier Inc. |
| record_format | MEDLINE/PubMed |
| spelling | pubmed-96715112022-11-18 Booster Effect of a Third mRNA-Based COVID-19 Vaccine Dose in Patients with Myeloid Malignancies Mori, Akio Onozawa, Masahiro Kobayashi, Mirei Tsukamoto, Shihori Senjo, Hajime Ishio, Takashi Yokoyama, Emi Izumiyama, Koh Saito, Makoto Muraki, Haruna Morioka, Masanobu Teshima, Takanori Kondo, Takeshi Blood Poster Abstracts The American Society of Hematology. Published by Elsevier Inc. 2022-11-15 2022-11-15 /pmc/articles/PMC9671511/ http://dx.doi.org/10.1182/blood-2022-159849 Text en Copyright © 2022 The American Society of Hematology. Published by Elsevier Inc. All rights reserved. Since January 2020 Elsevier has created a COVID-19 resource centre with free information in English and Mandarin on the novel coronavirus COVID-19. The COVID-19 resource centre is hosted on Elsevier Connect, the company's public news and information website. Elsevier hereby grants permission to make all its COVID-19-related research that is available on the COVID-19 resource centre - including this research content - immediately available in PubMed Central and other publicly funded repositories, such as the WHO COVID database with rights for unrestricted research re-use and analyses in any form or by any means with acknowledgement of the original source. These permissions are granted for free by Elsevier for as long as the COVID-19 resource centre remains active. |
| spellingShingle | Poster Abstracts Mori, Akio Onozawa, Masahiro Kobayashi, Mirei Tsukamoto, Shihori Senjo, Hajime Ishio, Takashi Yokoyama, Emi Izumiyama, Koh Saito, Makoto Muraki, Haruna Morioka, Masanobu Teshima, Takanori Kondo, Takeshi Booster Effect of a Third mRNA-Based COVID-19 Vaccine Dose in Patients with Myeloid Malignancies |
| title | Booster Effect of a Third mRNA-Based COVID-19 Vaccine Dose in Patients with Myeloid Malignancies |
| title_full | Booster Effect of a Third mRNA-Based COVID-19 Vaccine Dose in Patients with Myeloid Malignancies |
| title_fullStr | Booster Effect of a Third mRNA-Based COVID-19 Vaccine Dose in Patients with Myeloid Malignancies |
| title_full_unstemmed | Booster Effect of a Third mRNA-Based COVID-19 Vaccine Dose in Patients with Myeloid Malignancies |
| title_short | Booster Effect of a Third mRNA-Based COVID-19 Vaccine Dose in Patients with Myeloid Malignancies |
| title_sort | booster effect of a third mrna-based covid-19 vaccine dose in patients with myeloid malignancies |
| topic | Poster Abstracts |
| url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9671511/ http://dx.doi.org/10.1182/blood-2022-159849 |
| work_keys_str_mv | AT moriakio boostereffectofathirdmrnabasedcovid19vaccinedoseinpatientswithmyeloidmalignancies AT onozawamasahiro boostereffectofathirdmrnabasedcovid19vaccinedoseinpatientswithmyeloidmalignancies AT kobayashimirei boostereffectofathirdmrnabasedcovid19vaccinedoseinpatientswithmyeloidmalignancies AT tsukamotoshihori boostereffectofathirdmrnabasedcovid19vaccinedoseinpatientswithmyeloidmalignancies AT senjohajime boostereffectofathirdmrnabasedcovid19vaccinedoseinpatientswithmyeloidmalignancies AT ishiotakashi boostereffectofathirdmrnabasedcovid19vaccinedoseinpatientswithmyeloidmalignancies AT yokoyamaemi boostereffectofathirdmrnabasedcovid19vaccinedoseinpatientswithmyeloidmalignancies AT izumiyamakoh boostereffectofathirdmrnabasedcovid19vaccinedoseinpatientswithmyeloidmalignancies AT saitomakoto boostereffectofathirdmrnabasedcovid19vaccinedoseinpatientswithmyeloidmalignancies AT murakiharuna boostereffectofathirdmrnabasedcovid19vaccinedoseinpatientswithmyeloidmalignancies AT moriokamasanobu boostereffectofathirdmrnabasedcovid19vaccinedoseinpatientswithmyeloidmalignancies AT teshimatakanori boostereffectofathirdmrnabasedcovid19vaccinedoseinpatientswithmyeloidmalignancies AT kondotakeshi boostereffectofathirdmrnabasedcovid19vaccinedoseinpatientswithmyeloidmalignancies |